Literature DB >> 16447595

[Is necessary to practice orchiectomy in patients with post-puberal maldescended testes?].

E A Granados Loarca1, S Esau Ortega.   

Abstract

OBJECTIVE: The cryptorchidism is a risk factor for testicular cancer and is associated with cancer in the contraleteral testicle. The mechanism that leads to an increased risk of causes in a cryptorchid testis is unclear.
MATERIALS AND METHODS: We analyzed 25 patients of 20-years old for maldescended testicles we practiced orchiectomy in 22 testicles and orchiopexy in 7 testicles. The time patients had the testicles in an anomalous location were between 20-51 years.
RESULTS: The elder patients with maldescends testicles came because the couldn't feel the testicle in the scrotum and the 16% of them because of infertility. Only 1 of 25 cases (4%) were demonstrated cancer with pure seminoma.
CONCLUSIONS: In the following up of the patients none of them presented contralateral testicle cancer between 5-10 years. The patients who were practiced the orchiopexy no-one presented testicular cancer between 5-11 years.

Entities:  

Mesh:

Year:  2005        PMID: 16447595     DOI: 10.1016/s0210-4806(05)73378-7

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  3 in total

1.  The incidence and histological characteristics of intratubular germ cell neoplasia in postpubertal cryptorchid testis.

Authors:  Seung Hoon Ryang; Jae Hung Jung; Minseob Eom; Jae Mann Song; Hyun Chul Chung; Yunbyung Chae; Chang Min Lee; Kwang Jin Kim
Journal:  Korean J Urol       Date:  2015-06-30

2.  Prevalence of intratubular germ cell neoplasia in cryptorchid testes of infertile men.

Authors:  Fatemeh Pourkeramati; Haleh Soltanghoraee; Naser Amirjannati; Mohammad Mehdi Akhondi; Hamid Reza Reza Khorram Khorshid
Journal:  Iran J Reprod Med       Date:  2013-04

Review 3.  Individualized Treatment Guidelines for Postpubertal Cryptorchidism.

Authors:  Jae Min Chung; Sang Don Lee
Journal:  World J Mens Health       Date:  2015-12-23       Impact factor: 5.400

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.